Drug Trial Radar · NCT06443463
Long-term Safety and Tolerability of BHV-7000
Last checked: Nov 20, 2026Latest source record: May 1, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Enrolling by invitation
Enrollment
660
Planned (sponsor's estimate)
Start
Jul 30, 2024
Primary completion
Dec 2026
Study completion Jan 2027
Sponsor
- Lead sponsor
- Biohaven Therapeutics Ltd.Industry
- Sponsor type
- Industry
- First posted
- Jun 5, 2024
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Non randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 75 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
A study to determine if BHV- 7000 is safe and tolerable in adults with refractory focal onset epilepsy
Conditions
- Focal Epilepsy
Interventions
BHV-7000Drug
BHV-7000 50 mg. Participants will take open-label investigational product (IP) once daily
BHV-7000Drug
BHV-7000 75 mg. Participants will take open-label investigational product (IP) once daily
Primary outcomes
What the sponsor says the trial is designed to measure.
- Number of Participants With Deaths, Serious AEs (SAEs), AEs Leading to Study Drug Discontinuation, and moderate or severe AEsTime frame: Up to 104 weeks
- Number of Subjects with Clinically Significant Laboratory AbnormalitiesTime frame: Up to 104 weeks
Locations
283 sites in 27 countries. Site status is shown where the registry gives one.
Accel Research
Birmingham, Alabama
Onyx Clinical Trials
Peoria, Arizona
Xenoscience, Inc.
Phoenix, Arizona
University of Arizona / Banner University Medical Center Phoenix
Phoenix, Arizona
Barrow Neurological Institute
Phoenix, Arizona
ARENSIA Exploratory Medicine
Phoenix, Arizona
Center for Neurosciences
Tucson, Arizona
Clinical Trials, Inc.
Little Rock, Arkansas
WRN
Rogers, Arkansas
University of California San Diego
La Jolla, California
Amicis Research Center
Lancaster, California
Memorialcare Miller Children's & Women's Hospital Long Beach
Long Beach, California
University of California, Los Angeles
Los Angeles, California
Tri Valley Neurology Medical Associates, Inc.
Mission Hills, California
Stanford University
Palo Alto, California
Profound Research LLC
Pasadena, California
Profound Research LLC
Poway, California
Kaiser Permanente
Aurora, Colorado
University of Colorado Anschultz Medical Campus
Aurora, Colorado
UConn Health
Farmington, Connecticut
Yale School of Medicine - Yale-New Haven Hospital
New Haven, Connecticut
EZR Research LLC
Boca Raton, Florida
Nova Clinical Research, LLC
Bradenton, Florida
Las Mercedes Medical Research
Hialeah, Florida
Coral Clinic Research
Homestead, Florida
University of Florida (Jacksonville)
Jacksonville, Florida
Dm Healthworks
Kissimmee, Florida
University of Miami
Miami, Florida
Y&L Advance Health Care, Inc d/b/a Elite Clinical Research
Miami, Florida
Serenity Research Center
Miami, Florida
Floridian Research Institute
Miami, Florida
AdventHealth Orlando
Orlando, Florida
Research Institute of Orlando
Orlando, Florida
Comprehensive Neurology Clinic
Orlando, Florida
Panhandle Research & Medical Clinic
Pensacola, Florida
Medsol Clinical Research Center
Port Charlotte, Florida
Knight Neurology
Rockledge, Florida
PENS
Tampa, Florida
Santos Research Center
Tampa, Florida
Encore Medical Research of Weston LLC.
Weston, Florida
Showing 40 of 283 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.